¼¼°èÀÇ ½Å°æ°ú ȯÀÚ ¸ð´ÏÅ͸µ ½ÃÀå
Neurology Patient Monitoring
»óǰÄÚµå : 1787227
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 192 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,183,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,550,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ½Å°æ°ú ȯÀÚ ¸ð´ÏÅ͸µ ½ÃÀåÀº 2030³â±îÁö 68¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 48¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ½Å°æ°ú ȯÀÚ ¸ð´ÏÅ͸µ ½ÃÀåÀº 2024-2030³â¿¡ CAGR 6.0%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 68¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ¿Ü»ó ¾ÖÇø®ÄÉÀ̼ÇÀº CAGR 7.6%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á±îÁö 17¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. CSF °ü¸® ¾ÖÇø®ÄÉÀÌ¼Ç ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 7.1%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 13¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 9.7%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ½Å°æ°ú ȯÀÚ ¸ð´ÏÅ͸µ ½ÃÀåÀº 2024³â¿¡ 13¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 14¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 9.7%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 2.9%¿Í 6.0%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.0%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°è ½Å°æ°ú ȯÀÚ ¸ð´ÏÅ͸µ ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®

½Å°æ°ú ȯÀÚ ¸ð´ÏÅ͸µÀÌ Çö´ë ÀÇ·á¿¡ ÇʼöÀûÀÎ ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

½Å°æ°ú ȯÀÚ ¸ð´ÏÅ͸µÀº °£Áú, ³úÀüÁõ, ³úÁ¹Áß, ¿Ü»ó¼º ³ú¼Õ»ó(TBI), ´Ù¹ß¼º °æÈ­Áõ, ¾ËÃ÷ÇÏÀ̸Ӻ´, ÆÄŲ½¼º´°ú °°Àº ½Å°æÅðÇ༺ ÁúȯÀ» ¾Î°í Àִ ȯÀÚµéÀÇ ³ú Ȱµ¿, ÀÎÁö ±â´É, ½Å°æÇÐÀû ¹ÝÀÀÀ» ½Ç½Ã°£À¸·Î ÃßÀûÇÒ ¼ö ÀÖÀ¸¸ç, ÇコÄɾ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ¾Ò½À´Ï´Ù. ÇコÄɾ ÇʼöÀûÀÎ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀ» ÅëÇØ ÀÓ»óÀÇ´Â ¾ÇÈ­ ¡Èĸ¦ Á¶±â¿¡ ¹ß°ßÇϰí ÇÕº´ÁõÀ» ¿¹¹æÇϸç Ä¡·á Àü·«À» ÃÖÀûÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ³úÆÄ(EEG) ¹× µÎ°³³»¾Ð(ICP) ¸ð´ÏÅ͸µ°ú °°Àº ÀüÅëÀûÀÎ ½Å°æ ¸ð´ÏÅ͸µ ±â¼úÀº ¿©ÀüÈ÷ ³Î¸® »ç¿ëµÇ°í ÀÖÁö¸¸, ¿þ¾î·¯ºí EEG Çìµå¼Â, ±â´ÉÀû ±ÙÀû¿Ü¼± ºÐ±¤¹ý(fNIRS), ¹«¼± ½Å°æ ¿µ»ó°ú °°Àº ºñħ½ÀÀû ¸ð´ÏÅ͸µ ±â±âÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ ȯÀÚ È¯ÀÚ Ä¡·á´Â Å©°Ô Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ¿ø°ÝÀÇ·á ¹× µðÁöÅÐ Çコ Ç÷§Æû¿¡ ÈûÀÔ¾î ¿ø°Ý ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀÌ µîÀåÇϸ鼭 ÀÓ»ó ÇöÀå ¹Û¿¡¼­ ȯÀÚ¸¦ ¸ð´ÏÅ͸µÇϰí ÀÔ¿øÀ» ÁÙÀÌ¸ç ¸¸¼º ½Å°æÁúȯÀÇ Àå±âÀûÀÎ °ü¸®¸¦ °³¼±Çϰí ÀÖ½À´Ï´Ù. ÀΰøÁö´É(AI)°ú ºòµ¥ÀÌÅÍ ºÐ¼®Àº ½Å°æÇÐÀû ÀÌ»ó ÆÐÅÏÀÇ ÀÚµ¿ °¨Áö, Áúº´ ÁøÇà ¿¹Ãø, Ä¡·á °³ÀÔÀÇ °³º°È­¸¦ ÃËÁøÇÔÀ¸·Î½á ½Å°æ°ú ȯÀÚ ¸ð´ÏÅ͸µ¿¡ ¶Ç ´Ù¸¥ º¯È­¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù. ´Éµ¿ÀûÀÌ°í °³ÀÎÈ­µÈ ½Å°æÇÐÀû Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ȯÀÚ ¸ð´ÏÅ͸µ ±â¼úÀº ½Å°æÇÐÀ» ¹ÝÀÀÇü¿¡¼­ ¿¹Ãø ¹× ¿¹¹æ ÀÇ·á·Î ÀüȯÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.

½Å°æ°ú ȯÀÚ ¸ð´ÏÅ͸µ ±â¼ú µµÀÔÀ» °¡·Î¸·´Â °úÁ¦´Â?

Å« ÁøÀü¿¡µµ ºÒ±¸ÇÏ°í ½Å°æ°ú ȯÀÚ ¸ð´ÏÅ͸µÀº º¸±Þ¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¸î °¡Áö °úÁ¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ÁÖ¿ä Àå¾Ö¹° Áß Çϳª´Â °í±Þ ¸ð´ÏÅ͸µ ÀåºñÀÇ ³ôÀº ºñ¿ëÀ¸·Î, ƯÈ÷ ÁßÀú¼Òµæ ±¹°¡ÀÇ ¸¹Àº ÀÇ·á½Ã¼³¿¡¼­ Á¢±ÙÇÏ±â ¾î·Æ´Ù´Â Á¡ÀÔ´Ï´Ù. ¶ÇÇÑ Áö¼ÓÀûÀÎ ½Å°æ ¸ð´ÏÅ͸µÀ» ½Ç½ÃÇϱâ À§Çؼ­´Â ÀÇ·á Àü¹®°¡¿¡ ´ëÇÑ Àü¹®ÀûÀÎ ±³À°ÀÌ ÇÊ¿äÇϸç, ÀÚ¿øÀÌ Á¦ÇÑµÈ È¯°æ¿¡¼­ »ç¿ëÀÌ Á¦ÇѵǾî ÀÖ½À´Ï´Ù. ¶ÇÇÑ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀº ¹æ´ëÇÑ ¾çÀÇ ½Å°æÇÐÀû ±â¹Ð µ¥ÀÌÅ͸¦ »ý¼ºÇÏ°í ¾ÈÀüÇÏ°Ô ÀúÀå ¹× Àü¼ÛÇØ¾ß ÇϹǷΠµ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¹× »çÀ̹ö º¸¾È¿¡ ´ëÇÑ ¿ì·Áµµ Å« ¹®Á¦ÀÔ´Ï´Ù. ¼­·Î ´Ù¸¥ ½Å°æÇÐ ¸ð´ÏÅ͸µ Àåºñ¿Í º´¿ø Á¤º¸ ½Ã½ºÅÛ °£ÀÇ »óÈ£ ¿î¿ë¼º ¹®Á¦´Â ¿øÈ°ÇÑ ÅëÇÕÀ» ´õ¿í º¹ÀâÇÏ°Ô ¸¸µé°í, µ¥ÀÌÅÍ ÆÄÆíÈ­¿Í ȯÀÚ °ü¸®ÀÇ ºñÈ¿À²¼ºÀ» ÃÊ·¡ÇÕ´Ï´Ù. ¶Ç ´Ù¸¥ ¿ì·Á´Â ºñħ½ÀÀû ¸ð´ÏÅ͸µ ±â¼úÀÇ Á¤È®¼º°ú ½Å·Ú¼ºÀÔ´Ï´Ù. Àåºñ¿¡ µû¶ó¼­´Â ±âÁ¸ÀÇ Ä§½ÀÀû ¹æ¹ý¿¡ ºñÇØ ¹Î°¨µµ°¡ ³·À» ¼ö Àֱ⠶§¹®ÀÔ´Ï´Ù. »õ·Î¿î ½Å°æ ¸ð´ÏÅ͸µ ±â¼ú¿¡ ´ëÇÑ ±ÔÁ¦ À庮°ú ±ä ½ÂÀÎ ÀýÂ÷·Î ÀÎÇØ ½ÃÀå È®´ë°¡ Áö¿¬µÇ°í Çõ½ÅÀûÀÎ ¼Ö·ç¼Ç¿¡ ´ëÇÑ Á¢±ÙÀÌ ´Ê¾îÁö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °úÁ¦¸¦ ±Øº¹Çϱâ À§Çؼ­´Â ºñ¿ë È¿À²ÀûÀÎ ½Å°æ°ú ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç, Ç¥ÁØÈ­µÈ µ¥ÀÌÅÍ °øÀ¯ ÇÁ·ÎÅäÄÝ, ½Å°æ°ú ȯÀÚ Ä¡·áÀÇ Á¤È®¼º°ú È¿À²¼ºÀ» ³ôÀ̱â À§ÇÑ AI ±â¹Ý ºÐ¼®ÀÇ ¹ßÀü¿¡ ´ëÇÑ ÅõÀÚ°¡ ÇÊ¿äÇÕ´Ï´Ù.

±â¼ú Çõ½ÅÀº ½Å°æ°ú ȯÀÚ ¸ð´ÏÅ͸µÀ» ¾î¶»°Ô º¯È­½Ã۰í Àִ°¡?

½Å°æ°ú ȯÀÚ ¸ð´ÏÅ͸µ ½ÃÀå¿¡¼­´Â Áø´Ü Á¤È®µµ, Á¢±Ù¼º, ȯÀÚ ¿¹Èĸ¦ Å©°Ô °³¼±ÇÏ´Â ±â¼ú ¹ßÀüÀÌ ºü¸£°Ô ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. °¡Àå ÁÖ¸ñÇÒ ¸¸ÇÑ ±â¼ú Çõ½Å Áß Çϳª´Â ÀÓ»ó ÇöÀå ¹Û¿¡¼­µµ ½Ç½Ã°£À¸·Î ³úÀÇ È°µ¿À» ÃßÀûÇÒ ¼ö ÀÖ´Â ÈÞ´ë¿ë-Âø¿ëÇü ½Å°æ ¸ð´ÏÅ͸µ ÀåÄ¡ÀÇ °³¹ßÀÔ´Ï´Ù. ¹«¼± ³úÆÄ Çìµå¼Â°ú ¸ð¹ÙÀÏ ±â¹Ý ÀÎÁö Æò°¡ ÅøÀº °£Áú, ¼ö¸éÀå¾Ö µîÀÇ »óŸ¦ Áý¿¡¼­ ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ°Ô ÇÏ¿© ÀæÀº º´¿ø ¹æ¹®ÀÇ Çʿ伺À» ÁÙ¿©ÁÖ°í ÀÖ½À´Ï´Ù. AI ±â¹Ý ½Å°æ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ¶ÇÇÑ ³úÆÄ ÆÐÅÏÀ» ½Ç½Ã°£À¸·Î ºÐ¼®ÇÏ¿© ¹ßÀÛ È°µ¿°ú °°Àº ÀÌ»ó ¡Èĸ¦ °¨ÁöÇϰí, ÇÕº´ÁõÀÌ È®´ëµÇ±â Àü¿¡ ÀÇ·áÁø¿¡°Ô ÀáÀçÀû ÇÕº´ÁõÀ» °æ°íÇÔÀ¸·Î½á ȯÀÚ Ä¡·á¸¦ Çõ½ÅÀûÀ¸·Î º¯È­½Ã۰í ÀÖ½À´Ï´Ù. ±â´ÉÀû MRI(fMRI)¿Í ³ú ÀÚ±â°ø¸í¿µ»ó(MEG)°ú °°Àº ÷´Ü ½Å°æ¿µ»ó ±â¹ýÀº ³ú Ȱµ¿ ÃøÁ¤ÀÇ Á¤È®µµ¸¦ Çâ»ó½ÃÄÑ ½Å°æÁúȯ¿¡ ´ëÇÑ ´õ ±íÀº ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù. ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀ» À§ÇÑ Å¬¶ó¿ìµå ±â¹Ý Ç÷§ÆûÀÇ ÅëÇÕÀ¸·Î µ¥ÀÌÅÍ¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ ´õ¿í Çâ»óµÇ¾î ½Å°æ°ú Àü¹®Àǰ¡ Àå±âÀûÀ¸·Î Áúº´ÀÇ ÁøÇàÀ» ÃßÀûÇÏ°í ±×¿¡ µû¶ó Ä¡·á °èȹÀ» Á¶Á¤ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. °æµÎ°³ÀÚ±âÀÚ±Ø(TMS), ¹ÌÁֽŰæÀڱر⠵îÀÇ ½Å°æÀÚ±ØÀåÄ¡µµ ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ°ú ÅëÇÕµÇ¾î °³Àκ° ¸ÂÃã Ä¡·á¸¦ À§ÇÑ Æó¼â ·çÇÁ ½Å°æÁ¶Àý ¿ä¹ýÀ» °¡´ÉÇÏ°Ô Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀÌ °è¼Ó ¹ßÀüÇÔ¿¡ µû¶ó ½Å°æ°ú ȯÀÚ ¸ð´ÏÅ͸µÀº ´õ¿í È¿À²ÀûÀ̰í, ȯÀÚ Áß½ÉÀûÀ̸ç, ½Å°æÇÐÀû °Ç°­ »óŸ¦ °³¼±Çϱâ À§ÇÑ Á¶±â °³ÀÔÀ» Á¦°øÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

½Å°æ°ú ȯÀÚ ¸ð´ÏÅ͸µ ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº?

½Å°æ°ú ȯÀÚ ¸ð´ÏÅ͸µ ½ÃÀåÀÇ ¼ºÀåÀº ½Å°æÁúȯÀÇ À¯º´·ü Áõ°¡, ºñħ½ÀÀû ¹× ¿ø°Ý ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, AI ±â¹Ý ºÐ¼®ÀÇ ¹ßÀü µî ¿©·¯ °¡Áö ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. °£Áú, ³úÁ¹Áß, ÆÄŲ½¼º´, ¾ËÃ÷ÇÏÀ̸Ӻ´ÀÇ ¹ßº´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Áúº´ÀÇ ÁøÇàÀ» È¿°úÀûÀ¸·Î °ü¸®Çϱâ À§ÇÑ Áö¼ÓÀûÀÎ ½Å°æÇÐÀû ¸ð´ÏÅ͸µÀÇ Çʿ伺ÀÌ ´ëµÎµÇ°í ÀÖ½À´Ï´Ù. ÀçÅÃÄ¡·á ¹× ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀ¸·ÎÀÇ ÀüȯÀº ¿þ¾î·¯ºí ½Å°æ ¸ð´ÏÅ͸µ ÀåÄ¡°¡ Àå±âÀûÀÎ ½Å°æÇÐ Ä¡·á¿¡ ³Î¸® äÅÃµÇ¾î ½ÃÀå ±âȸ¸¦ ´õ¿í È®´ë½Ã۰í ÀÖ½À´Ï´Ù. ½Å°æ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ¿¡ AI¿Í ¸Ó½Å·¯´×À» ÅëÇÕÇÏ¿© ½Ç½Ã°£ µ¥ÀÌÅÍ ºÐ¼®, ÀÚµ¿ ÀÌ»ó °¨Áö, ½Å°æÁúȯÀÇ ¿¹Ãø ºÐ¼®ÀÌ °¡´ÉÇØÁö¸é¼­ ½ÃÀå ¼ºÀåµµ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ½Å°æ°ú ȯÀÚ Ä¡·á °³¼±À» À§ÇÑ Á¤ºÎÀÇ ±¸»ó°ú ÇコÄɾî Á¤Ã¥Àº Çõ½ÅÀûÀÎ ¸ð´ÏÅ͸µ ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ¸¦ ÃËÁøÇϰí ÀÖÀ¸¸ç, ½Å°æ ±â¼ú ¿¬±¸¿¡ ´ëÇÑ ÀÚ±Ý Áö¿ø Áõ°¡´Â Â÷¼¼´ë ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç °³¹ßÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù. ¿ø°ÝÀÇ·á¿Í µðÁöÅÐ Çコ Ç÷§ÆûÀÇ È®ÀåÀº ½Å°æÇÐ ¸ð´ÏÅ͸µ Åø¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» ´õ¿í °­È­ÇÏ¿© ½Å°æÇÐ Ä¡·á¸¦ ´õ¿í Ä£¼÷ÇÏ°í ´Éµ¿ÀûÀ¸·Î ¸¸µé°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀÌ ½ÃÀå ȯ°æÀ» °è¼Ó Çü¼ºÇØ ³ª°¡¸é¼­ ½ÃÀåÀº Áö¼ÓÀûÀ¸·Î ¼ºÀåÇϰí, ½Å°æÇÐÀû Ä¡·á¿¡ º¯È­¸¦ °¡Á®¿À°í, Àü ¼¼°è ȯÀÚµéÀÇ Ä¡·á °á°ú¸¦ °³¼±ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºÎ¹®

¾ÖÇø®ÄÉÀ̼Ç(¿Ü»ó ¾ÖÇø®ÄÉÀ̼Ç, °ñ¼ö¾× °ü¸® ¾ÖÇø®ÄÉÀ̼Ç, ÆíµÎÅë ¾ÖÇø®ÄÉÀ̼Ç, ³úÁ¹Áß ¾ÖÇø®ÄÉÀ̼Ç, ¼öµÎÁõ ¾ÖÇø®ÄÉÀ̼Ç, ³úÆÄ ¾ÖÇø®ÄÉÀ̼Ç, ±âŸ ¾ÖÇø®ÄÉÀ̼Ç)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

´ç»ç´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Neurology Patient Monitoring Market to Reach US$6.8 Billion by 2030

The global market for Neurology Patient Monitoring estimated at US$4.8 Billion in the year 2024, is expected to reach US$6.8 Billion by 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Trauma Application, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the CSF Management Application segment is estimated at 7.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.3 Billion While China is Forecast to Grow at 9.7% CAGR

The Neurology Patient Monitoring market in the U.S. is estimated at US$1.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 9.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 6.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Neurology Patient Monitoring Market - Key Trends & Drivers Summarized

Why Is Neurology Patient Monitoring Becoming Essential in Modern Healthcare?

Neurology patient monitoring has become an indispensable aspect of healthcare, enabling real-time tracking of brain activity, cognitive function, and neurological responses in individuals suffering from conditions such as epilepsy, stroke, traumatic brain injuries (TBI), multiple sclerosis, and neurodegenerative diseases like Alzheimer’s and Parkinson’s. Continuous monitoring allows clinicians to detect early signs of deterioration, prevent complications, and optimize treatment strategies. Traditional neuromonitoring techniques, such as electroencephalography (EEG) and intracranial pressure (ICP) monitoring, remain widely used, but advances in non-invasive monitoring devices, including wearable EEG headsets, functional near-infrared spectroscopy (fNIRS), and wireless neuroimaging, are significantly enhancing patient care. The rise of remote monitoring solutions, driven by telemedicine and digital health platforms, is also enabling patients to be monitored outside of clinical settings, reducing hospital admissions and improving long-term management of chronic neurological disorders. Artificial intelligence (AI) and big data analytics are further revolutionizing neurology patient monitoring by facilitating automated detection of abnormal neurological patterns, predicting disease progression, and personalizing treatment interventions. As the demand for proactive and personalized neurological care increases, patient monitoring technologies are playing a critical role in transforming neurology from reactive to predictive and preventive medicine.

What Challenges Are Hindering the Adoption of Neurology Patient Monitoring Technologies?

Despite significant advancements, neurology patient monitoring faces several challenges that impact its widespread adoption. One of the key obstacles is the high cost of advanced monitoring devices, making them inaccessible to many healthcare facilities, especially in low- and middle-income countries. The implementation of continuous neuromonitoring also requires specialized training for healthcare professionals, limiting its availability in resource-constrained settings. Additionally, data privacy and cybersecurity concerns are major challenges, as patient monitoring systems generate vast amounts of sensitive neurological data that must be securely stored and transmitted. Interoperability issues between different neurology monitoring devices and hospital information systems further complicate seamless integration, leading to fragmented data and inefficiencies in patient management. Another concern is the accuracy and reliability of non-invasive monitoring techniques, as some devices may have lower sensitivity compared to traditional invasive methods. Regulatory hurdles and lengthy approval processes for new neuromonitoring technologies also slow down market expansion, delaying access to innovative solutions. Overcoming these challenges requires investments in cost-effective neurology monitoring solutions, standardized data-sharing protocols, and advancements in AI-driven analytics to enhance accuracy and efficiency in neurology patient care.

How Are Technological Innovations Revolutionizing Neurology Patient Monitoring?

The neurology patient monitoring market is experiencing a surge in technological advancements that are significantly improving diagnostic accuracy, accessibility, and patient outcomes. One of the most notable innovations is the development of portable and wearable neuro-monitoring devices that allow real-time tracking of brain activity outside of clinical settings. Wireless EEG headsets and mobile-based cognitive assessment tools are enabling home-based monitoring of conditions such as epilepsy and sleep disorders, reducing the need for frequent hospital visits. AI-powered neuromonitoring systems are also transforming patient care by analyzing brainwave patterns in real-time, detecting abnormalities such as seizure activity, and alerting healthcare providers to potential complications before they escalate. Advanced neuroimaging modalities, including functional MRI (fMRI) and magnetoencephalography (MEG), are improving the precision of brain activity measurements, providing deeper insights into neurological disorders. The integration of cloud-based platforms for remote patient monitoring is further enhancing data accessibility, allowing neurologists to track disease progression over time and adjust treatment plans accordingly. Neurostimulation devices, such as transcranial magnetic stimulation (TMS) and vagus nerve stimulators, are also being integrated with patient monitoring systems, enabling closed-loop neuromodulation therapies for personalized treatment. As these technologies continue to evolve, neurology patient monitoring is becoming more efficient, patient-centric, and capable of delivering early interventions that improve neurological health outcomes.

What Is Driving the Growth of the Neurology Patient Monitoring Market?

The growth in the neurology patient monitoring market is driven by several factors, including the increasing prevalence of neurological disorders, rising demand for non-invasive and remote monitoring solutions, and advancements in AI-driven analytics. The growing incidence of epilepsy, stroke, Parkinson’s disease, and Alzheimer’s is fueling the need for continuous neurological monitoring to manage disease progression effectively. The shift toward home-based healthcare and remote patient monitoring is further expanding market opportunities, as wearable neuromonitoring devices become more widely adopted for long-term neurological care. The integration of AI and machine learning in neuromonitoring systems is also accelerating market growth by enabling real-time data analysis, automated anomaly detection, and predictive analytics for neurological conditions. Government initiatives and healthcare policies aimed at improving neurology patient care are fostering investments in innovative monitoring technologies, while increased funding in neurotechnology research is supporting the development of next-generation monitoring solutions. The expansion of telemedicine and digital health platforms is further enhancing access to neurology monitoring tools, making neurological care more accessible and proactive. As these trends continue to shape the neurology patient monitoring landscape, the market is expected to witness sustained growth, transforming neurological care and improving outcomes for patients worldwide.

SCOPE OF STUDY:

The report analyzes the Neurology Patient Monitoring market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Trauma Application, CSF Management Application, Migraine Application, Stroke Application, Hydrocephalus Application, EEG Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 39 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â